Flyer

Archives of Clinical Microbiology

  • ISSN: 1989-8436
  • Journal h-index: 24
  • Journal CiteScore: 8.01
  • Journal Impact Factor: 7.55
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • The Global Impact Factor (GIF)
  • Open Archive Initiative
  • China National Knowledge Infrastructure (CNKI)
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • Scimago Journal Ranking
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page

Bunyavirus: A group of ancient, but newly defined virus

EuroSciCon Conference on Virology and Infectious Diseases
April 22-23, 2019 | Athens, Greece

Yan Wu

Beijing Institutes of Life Science-Chinese Academy of Sciences, China

Posters & Accepted Abstracts: Arch Clin Microbiol

Abstract:

Buniyavirales order is one of the largest groups of RNA viruses, including more than 350 members distributed among ten families according to the latest International Committee on Taxonomy of Viruses (ICTV) report. Some of them can cause disease in humans, including highly pathogenic Crimean-Congo hemorrhagic fever virus (CCHFV) in the Nairoviridae family; the Rift Valley fever virus (RVFV), the severe fever with thrombocytopenia syndrome virus (SFTSV) in the Phenuiviridae family; Lacrosse virus and Oropouche virus in the Peribunyaviridae family and several hantaviruses such as Hantaan virus, Sin Nombre virus, Andes virus in the Hantaviridae family. Only vaccines for HTNV and SEOV have been developed in Asia. And no specific drugs are available against these contagious Bunyaviruses. The glycoproteins (Gn and Gc) on the Bunyaviruses play an important role in particle entry into the target cells. They are also the major antigens which arise neutralizing antibodies in human body against the infection. This research focuses on the structural and functional studies of the envelope proteins of RVFV and SFTSV and fished the neutralizing antibodies from the RVFV infected patients’ PBMCs using the recombinant glycoproteins and then explored the neutralizing mechanisms based on the antigen-antibody complex structures. These studies provide potential specific drugs against RVFV and also provide the detailed information of epitope of the antigen, thereby paving way on the vaccine development.

Biography :

E-mail:

wuy@biols.ac.cn